ATRX is a regulator of therapy induced senescence in human cells
Therapy induced senescence (TIS) is a growth suppressive program activated by cytostatic agents in some cancer cells. Here the authors show that the chromatin remodeling enzyme ATRX is a regulator of TIS and drives cells into this state via multiple mechanisms.
Guardado en:
Autores principales: | Marta Kovatcheva, Will Liao, Mary E. Klein, Nicolas Robine, Heather Geiger, Aimee M. Crago, Mark A. Dickson, William D. Tap, Samuel Singer, Andrew Koff |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7f628acc50d64801af6befbeedb96ee3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Disruption of ATRX-RNA interactions uncovers roles in ATRX localization and PRC2 function
por: Wenqing Ren, et al.
Publicado: (2020) -
MYCN amplification and ATRX mutations are incompatible in neuroblastoma
por: Maged Zeineldin, et al.
Publicado: (2020) -
Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX
por: Alexandre de Nonneville, et al.
Publicado: (2021) -
Formal reply to “Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX”
por: Lars Feuerbach
Publicado: (2021) -
ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma
por: Husam Babikir, et al.
Publicado: (2021)